Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

被引:263
作者
Lucas, GM [1 ]
Gebo, KA [1 ]
Chaisson, RE [1 ]
Moore, RD [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
关键词
HIV-1; substance abuse; antiretroviral therapy; CD4 cell count; RNA;
D O I
10.1097/00002030-200203290-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To assess the temporal association of changes in substance abuse with antiretroviral therapy use and adherence, HIV-1 RNA suppression, and CD4 cell count changes in patients attending an urban clinic. Design: Prospective cohort study. Methods: Six-hundred and ninety-five HIV-1-infected individuals, who completed two or more semi-annual standardized surveys and in whom antiretroviral therapy was indicated, were included in the analysis. Surveys addressed antiretroviral therapy use and adherence, and use of illicit drugs and alcohol. Substance abuse was defined as active heroin, cocaine, or heavy alcohol use in the 6 months preceding survey. The units of analysis were consecutive pairs of surveys (couplets) in individual participants. Couplets in which participants denied substance abuse in both surveys were compared to couplets in which participants switched from non-use to substance abuse, and couplets in which participants reported substance abuse in both surveys were compared to couplets where participants switched from substance abuse to non-use. Results: Switching from non-use to substance abuse was strongly associated with worsening antiretroviral therapy use and adherence, less frequent HIV-1 RNA suppression, and blunted CD4 cell increases, compared to remaining free of substance abuse. Alternatively, switching from substance abuse to non-use was strongly associated with improvements in antiretroviral therapy use and adherence, and HIV-1 treatment outcomes, compared to persisting with substance abuse. Conclusions: This longitudinal study highlights the dynamic nature of substance abuse and its temporal association with the effectiveness of HIV-1 treatment in patients attending an inner-city clinic. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:767 / 774
页数:8
相关论文
共 35 条
[1]  
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[2]  
Bangsberg DR, 2001, J ACQ IMMUN DEF SYND, V26, P435, DOI 10.1097/00126334-200104150-00005
[3]  
*CDCP, 1999, 11 CDCP
[4]   Self-reported antiretroviral therapy in injection drug users [J].
Celentano, DD ;
Vlahov, D ;
Cohn, S ;
Shadle, VM ;
Obasanjo, O ;
Moore, RD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (06) :544-546
[5]   Medication adherence among HIV-infected patients: Understanding the complex behavior of patients taking this complex therapy [J].
Laura W. Cheever ;
Albert W. Wu .
Current Infectious Disease Reports, 1999, 1 (4) :401-407
[6]   Antiretroviral therapy for drug users [J].
Clarke, SM ;
Mulcahy, FM .
INTERNATIONAL JOURNAL OF STD & AIDS, 2000, 11 (10) :627-631
[7]   Problem drinking and medication adherence among persons with HIV infection [J].
Cook, RL ;
Sereika, SM ;
Hunt, SC ;
Woodward, WC ;
Erlen, JA ;
Conigliaro, J .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (02) :83-88
[8]  
*DEP HHS HJ KAIS F, 2001, GUID US ANT AG HIV I
[9]   Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease [J].
Ferrando, SJ ;
Wall, TL ;
Batki, SL ;
Sorensen, JL .
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 1996, 22 (04) :475-487
[10]   PRIMARY CARE PHYSICIANS AND AIDS - ATTITUDINAL AND STRUCTURAL BARRIERS TO CARE [J].
GERBERT, B ;
MAGUIRE, BT ;
BLEECKER, T ;
COATES, TJ ;
MCPHEE, SJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (20) :2837-2842